Hematology

Maximizing the Therapeutic Potential of Janus Kinase 2 (JAK2) Inhibitors in Patients with Chronic Myelofibrosis
http://academiccme.com/wp-content/uploads/2015/06/27_Website-Graphic-wpcf_80x80.png
A webcast from the live, satellite symposium at ASH 2014 will cover clinical trial data on JAK2 inhibitor therapeutics, and how it has changed the clinical approach to patients with this illness…
Webcast